Alpine Immune Sciences Stock Number Of Shares Shorted
| ALPNDelisted Stock | USD 7.90 0.00 0.00% |
Alpine Immune Sciences fundamentals help investors to digest information that contributes to Alpine Immune's financial success or failures. It also enables traders to predict the movement of Alpine Stock. The fundamental analysis module provides a way to measure Alpine Immune's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alpine Immune stock.
Alpine |
Alpine Immune Sciences Company Number Of Shares Shorted Analysis
Alpine Immune's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Alpine Immune Number Of Shares Shorted | 3.89 M |
Most of Alpine Immune's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alpine Immune Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Alpine Immune Sciences has 3.89 M of outstending shares currently sold short by investors. This is 21.53% higher than that of the Biotechnology sector and 23.72% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 17.37% higher than that of the company.
Alpine Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alpine Immune's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alpine Immune could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics of similar companies.Alpine Immune is currently under evaluation in number of shares shorted category among its peers.
Alpine Fundamentals
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.1 | ||||
| Profit Margin | (0.65) % | ||||
| Operating Margin | (3.23) % | ||||
| Current Valuation | 4.16 B | ||||
| Shares Outstanding | 68.6 M | ||||
| Shares Owned By Insiders | 4.60 % | ||||
| Shares Owned By Institutions | 99.46 % | ||||
| Number Of Shares Shorted | 3.89 M | ||||
| Price To Earning | (32.69) X | ||||
| Price To Book | 12.87 X | ||||
| Price To Sales | 71.68 X | ||||
| Revenue | 58.88 M | ||||
| Gross Profit | (40.18 M) | ||||
| EBITDA | (43.67 M) | ||||
| Net Income | (32.18 M) | ||||
| Cash And Equivalents | 167.86 M | ||||
| Cash Per Share | 5.52 X | ||||
| Total Debt | 9.91 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 2.75 X | ||||
| Book Value Per Share | 5.08 X | ||||
| Cash Flow From Operations | (79.01 M) | ||||
| Short Ratio | 0.96 X | ||||
| Earnings Per Share | (0.64) X | ||||
| Target Price | 62.0 | ||||
| Number Of Employees | 142 | ||||
| Beta | 0.97 | ||||
| Market Capitalization | 4.46 B | ||||
| Total Asset | 381.81 M | ||||
| Retained Earnings | (256.14 M) | ||||
| Working Capital | 288.05 M | ||||
| Current Asset | 25.53 M | ||||
| Current Liabilities | 3.39 M | ||||
| Net Asset | 381.81 M |
About Alpine Immune Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alpine Immune Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpine Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpine Immune Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Alpine Stock
If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |